AMENDMENT NO. 4Credit Agreement • November 25th, 2020 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of August 1, 2017 (this “Agreement”), by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), a Delaware corporation (“INC Holdings” or the “Administrative Borrower”), the entities listed on Schedule I hereto (each a “Borrower” and collectively with the Administrative Borrower, the “Borrowers”), the Lenders from time to time party hereto, JPMorgan Chase Bank, N.A. (as successor to Credit Suisse AG, Cayman Islands Branch (“Credit Suisse”)), as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”), and ING Capital LLC (“ING”), Goldman Sachs Bank USA, BofA Securities, Inc. Morgan Stanley Senior Funding, Inc., Citibank, N.A., Fifth Third Bank, National Association, JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, Regions Capital Markets, a Division of Regions Bank, MUFG Bank, Ltd. and Wells Fargo Securities, LLC, Truist Securities, Inc., Keybank National Association and TD Securities (USA) LLC,
SYNEOS HEALTH, INC. as Issuer EACH OF THE GUARANTORS PARTY HERETO as Guarantors WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee First Supplemental Indenture Dated as of November 24, 2020 to the Indenture dated as of November 24, 2020 3.625% Senior...Indenture • November 25th, 2020 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of November 24, 2020, among Syneos Health, Inc., a Delaware corporation (the “Company”), the Guarantors listed on Schedule A hereto (the “Guarantors”) and Wells Fargo Bank, National Association (the “Trustee”), as trustee under the Indenture, dated as of November 24, 2020, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).
